from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1415/ribA2

LFCtreatmentdescriptionclass of inhibitor

-0.772

Amikacinug/mL Amikacintranslation

-0.930

Cap5-10ug/mL Capreomycintranslation

-1.186

Rox10-50 ug/mL Roxithromycintranslation

-0.366

SM2-5 ug/mL Streptomycintranslation

-2.180

Tet5-10 ug/mL Tetracyclinetranslation

-0.092

Rif0.2-5ug/mL Rifampicintranscription

-0.719

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.386

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.444

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.765

CPZ10-50 ug/mL Chlorpromazinerespiration

1.367

Clofazimine10-13 ug/mL Clofaziminerespiration

1.044

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.346

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.974

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.897

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.878

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.081

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.642

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.144

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.112

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.173

KCN5-20 ug/mL Potassium cyaniderespiration

0.885

NaN30.2-2 mM Sodium aziderespiration

-0.001

Nigericin50 uM Nigericinrespiration

0.559

TRC10-150 ug/mL Triclosanrespiration

1.386

TRZ10-25 ug/mL Thioridazinerespiration

-0.836

Valinomycin0.5-10 uM Valinomycinrespiration

0.613

ZnSO42 mM ZnSO4respiration

0.150

menadione6-10 ug/mL Menadionerespiration

-0.078

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.531

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.670

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.667

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.238

NRP_1Non-replicating persistence stage 1dosRassociated

-0.090

Amp0.2mg/mL AmpicillincellWall

-0.381

Cephalexin20-100 ug/mL CephalexincellWall

-0.805

Cerulenin0.32-5 ug/mL CerulenincellWall

0.402

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.081

EMB10-20 ug/mL EthambutolcellWall

-0.482

Eta12-40 ug/mL EthionamidecellWall

-0.626

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.577

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.173

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.683

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.121

BZA0.12 mg/mL BenzamidearomaticAmides

-0.150

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.329

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.914

H2O24 mM hydrogen peroxideDNAdamaging

-0.301

Levo10 ug/mL LevofloxacinDNAdamaging

-1.078

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.642

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.134

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.414

UVUV-irradiationDNAdamaging

0.861

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.786

Antimycin12.5-50 ug/mL Antimycin A?

-0.455

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.752

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.257

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.175

PA8240.2-2 ug/mL PA-824?

0.976

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.842

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.101

Verapamil50 uM Verapamil?

-0.056

mercaptoethanol2 mM 2-Mercaptoethanol?

0.006

methoxatin10-20 ug/mL Methoxatin?